Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bron

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Current Opinion in Oncology|August 16, 2020
Chimeric antigen receptor T-cell lymphoma immunotherapy: the next questionsAdriano Salaroli, Chloé Spilleboudt, Dominique Bron, et al.
Annals of Hematology|October 1, 2016
Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysisHampig Raphael Kourie, Lieveke Ameye, Marianne Paesmans, et al.
Current Opinion in Oncology|August 19, 2021
Hepatosplenic T-cell lymphoma: treatment challengesDominique Bron, Laurence De Leval, Sandra Michiels, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 4, 2016
Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-AnalysisHampig Raphael Kourie, Lieveke Ameye, Marianne Paesmans, et al.
British Journal of Haematology|July 20, 2016
Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysisHampig Raphael Kourie, Lieveke Ameye, Marianne Paesmans, et al.
British Journal of Haematology|July 9, 2002
Infusion of peripheral blood stem cells collected at diagnosis, with maintenance of the treatment, resulted in Ph-negative recovery in a chronic myeloid leukaemia patient in persisting aplasia on STI-571 therapyPhilippe Lewalle, Nathalie Meuleman, Alain Verhest, et al.
Cancers|February 25, 2022
Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective AnalysisFulvio Massaro, Nathalie Meuleman, Dominique Bron, et al.
Immune Network|May 2, 2017
Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical ReviewMehdi Najar, Mohammad Krayem, Nathalie Meuleman, et al.
Haematologica|April 2, 2015
Aging and blood disorders: new perspectives, new challengesDominique Bron, Lionel Ades, Tamas Fulop, et al.
Clinical Case Reports|July 8, 2016
Diagnosis of congenital von Willebrand disease during a preoperative assessment in a multiple myeloma patient without bleeding historyMalika El Ouaaliti, Rong Li, Delphine Gobin, et al.
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Current Opinion in Oncology|August 16, 2020
Chimeric antigen receptor T-cell lymphoma immunotherapy: the next questionsAdriano Salaroli, Chloé Spilleboudt, Dominique Bron, et al.
Annals of Hematology|October 1, 2016
Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysisHampig Raphael Kourie, Lieveke Ameye, Marianne Paesmans, et al.
Current Opinion in Oncology|August 19, 2021
Hepatosplenic T-cell lymphoma: treatment challengesDominique Bron, Laurence De Leval, Sandra Michiels, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 4, 2016
Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-AnalysisHampig Raphael Kourie, Lieveke Ameye, Marianne Paesmans, et al.
British Journal of Haematology|July 20, 2016
Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysisHampig Raphael Kourie, Lieveke Ameye, Marianne Paesmans, et al.
British Journal of Haematology|July 9, 2002
Infusion of peripheral blood stem cells collected at diagnosis, with maintenance of the treatment, resulted in Ph-negative recovery in a chronic myeloid leukaemia patient in persisting aplasia on STI-571 therapyPhilippe Lewalle, Nathalie Meuleman, Alain Verhest, et al.
Cancers|February 25, 2022
Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective AnalysisFulvio Massaro, Nathalie Meuleman, Dominique Bron, et al.
Immune Network|May 2, 2017
Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical ReviewMehdi Najar, Mohammad Krayem, Nathalie Meuleman, et al.
Haematologica|April 2, 2015
Aging and blood disorders: new perspectives, new challengesDominique Bron, Lionel Ades, Tamas Fulop, et al.
Clinical Case Reports|July 8, 2016
Diagnosis of congenital von Willebrand disease during a preoperative assessment in a multiple myeloma patient without bleeding historyMalika El Ouaaliti, Rong Li, Delphine Gobin, et al.
Pageof 17